We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » cGMP Violations at Lex Plant Draw Warning From the FDA
cGMP Violations at Lex Plant Draw Warning From the FDA
February 7, 2005
The FDA has cited Florida-based Lex Pharmaceutical following an FDA inspection that revealed multiple manufacturing violations at the company’s Medley, Fla., plant.